74 related articles for article (PubMed ID: 7117362)
1. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities.
Hurwitz JL; Herber-Katz E; Hackett CJ; Gerhard W
J Immunol; 1984 Dec; 133(6):3371-7. PubMed ID: 6208279
[TBL] [Abstract][Full Text] [Related]
3. [Role of antineuraminidase antibodies in protection against influenza].
Aymard M; Gerentes L; Kessler N
Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
[TBL] [Abstract][Full Text] [Related]
4. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
Mozdzanowska K; Maiese K; Furchner M; Gerhard W
Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581
[TBL] [Abstract][Full Text] [Related]
5. [Differentiation of equine influenza viruses subtype 2 with monoclonal antibodies].
Eichhorn W
Tierarztl Prax Suppl; 1987; 2():41-6. PubMed ID: 3590159
[TBL] [Abstract][Full Text] [Related]
6. The reactions of monoclonal antibodies with structural proteins of mumps virus.
Orvell C
J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
[TBL] [Abstract][Full Text] [Related]
7. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
8. Preparation of anti-idiotypic antibody against avian influenza virus subtype H9.
Li B; Peng J; Niu Z; Yin X; Liu F
Cell Mol Immunol; 2005 Apr; 2(2):155-7. PubMed ID: 16191424
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
11. Analysis of influenza A virus neuraminidase using lectin test and monoclonal antibodies.
Varecková E; Lyubovtseva OV; Russ G; Styk B; Zakstelskaya LYa ; Yakhno MA
Acta Virol; 1986 Jul; 30(4):281-8. PubMed ID: 2876609
[TBL] [Abstract][Full Text] [Related]
12. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
Johansson BE; Moran TM; Bona CA; Kilbourne ED
J Immunol; 1987 Sep; 139(6):2015-9. PubMed ID: 2957444
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice.
Fazekas G; Rajnavölgyi E; Kurucz I; Sintár E; Kiss K; László G; Gergely J
Eur J Immunol; 1990 Dec; 20(12):2719-29. PubMed ID: 2269331
[TBL] [Abstract][Full Text] [Related]
14. The equilibrium constant for the interaction between a monoclonal Fab fragment and an influenza virus neuraminidase.
Jackson DC; Howlett GJ; Nestorowicz A; Webster RG
J Immunol; 1983 Mar; 130(3):1313-6. PubMed ID: 6822736
[TBL] [Abstract][Full Text] [Related]
15. Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities.
Yewdell J; Gerhard W
J Immunol; 1982 Jun; 128(6):2670-5. PubMed ID: 6281335
[TBL] [Abstract][Full Text] [Related]
16. Murine TH response to influenza virus: recognition of hemagglutinin, neuraminidase, matrix, and nucleoproteins.
Hurwitz JL; Hackett CJ; McAndrew EC; Gerhard W
J Immunol; 1985 Mar; 134(3):1994-8. PubMed ID: 3155776
[TBL] [Abstract][Full Text] [Related]
17. Hybrid antibody-mediated lysis of virus-infected cells.
Staerz UD; Yewdell JW; Bevan MJ
Eur J Immunol; 1987 Apr; 17(4):571-4. PubMed ID: 3494618
[TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies specific for sequential influenza A/PR/8/34 virus variants.
Reale MA; Manheimer AJ; Moran TM; Norton G; Bona CA; Schulman JL
J Immunol; 1986 Aug; 137(4):1352-8. PubMed ID: 2426361
[TBL] [Abstract][Full Text] [Related]
19. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
Lambre CR; Thibon M; Le Maho S; Di Bella G
Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
[TBL] [Abstract][Full Text] [Related]
20. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin.
Kavaler J; Caton AJ; Staudt LM; Schwartz D; Gerhard W
J Immunol; 1990 Oct; 145(7):2312-21. PubMed ID: 2118933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
